BTI
TMO icon

Blue Trust Inc’s Thermo Fisher Scientific TMO Stock Holding History

Blue Trust Inc’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Buy
2,393
+75
+3% +$36K 0.01% 263
2026
Q1 		$1.14M Buy
2,318
+1,185
+105% +$643K 0.01% 264
2025
Q4 		$657K Sell
1,133
-96
-8% -$54.3K 0.01% 392
2025
Q3 		$596K Sell
1,229
-6
-0.5% -$2.79K 0.01% 436
2025
Q2 		$501K Sell
1,235
-14
-1% -$5.85K 0.01% 444
2025
Q1 		$621K Buy
1,249
+225
+22% +$122K 0.01% 357
2024
Q4 		$533K Sell
1,024
-685
-40% -$377K 0.01% 360
2024
Q3 		$945K Buy
1,709
+880
+106% +$521K 0.01% 288
2024
Q2 		$482K Buy
829
+193
+30% +$111K 0.01% 392
2024
Q1 		$370K Sell
636
-215
-25% -$121K 0.01% 336
2023
Q4 		$430K Buy
851
+48
+6% +$23.2K 0.01% 270
2023
Q3 		$419K Buy
803
+78
+11% +$41.6K 0.01% 280
2023
Q2 		$418K Sell
725
-360
-33% -$194K 0.01% 256
2023
Q1 		$597K Sell
1,085
-695
-39% -$392K 0.01% 259
2022
Q4 		$902K Buy
1,780
+552
+45% +$292K 0.02% 186
2022
Q3 		$667K Buy
1,228
+412
+50% +$231K 0.01% 180
2022
Q2 		$482K Buy
+816
New +$449K 0.01% 195

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Blue Trust Inc's TMO Position: Q2 2026 in Review

Blue Trust Inc increased its Thermo Fisher Scientific (TMO) stake by 3.2% in Q2 2026, buying an estimated $36K and bringing the position to 2,393 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #263.

Blue Trust Inc first reported a position in TMO in Q2 2022 and has held it in 17 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Blue Trust Inc held 2,393 shares of Thermo Fisher Scientific worth $1.2M as of Q2 2026.
  • Blue Trust Inc bought 75 Thermo Fisher Scientific shares in Q2 2026, an estimated $36K.
  • Thermo Fisher Scientific made up 0.01% of Blue Trust Inc's portfolio in Q2 2026, its #263 holding.
  • Blue Trust Inc first reported a position in Thermo Fisher Scientific in Q2 2022 and has held it in 17 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.